Peptide affiliate marketing — UK legal risks
Affiliate marketing for peptides sits in the intersection of UK advertising rules (ASA / CAP), consumer-protection law (CPRs 2008, CMA), and medicines law (HMR 2012, MHRA). The disclosure question is the smaller half; the substantive question is whether the underlying supply or product is lawful in the first place. This page sets out the framework for publishers, influencers, gyms, and clinics considering affiliate revenue from peptide-adjacent products.
What counts as a ‘material connection’
The ASA and CMA use the term material connection to describe any commercial relationship that triggers disclosure obligations. It’s broader than “paid partnership.” Material connections include:
- Cash payment for the post.
- Affiliate commission on any sales the post drives.
- Free product or services.
- Discount codes that you personally benefit from.
- Equity in the brand or company.
- Employment or contractor relationship.
- Family relationship with the brand.
- Reciprocal promotion arrangements (you promote them, they promote you).
Any of these means the post is advertising. Failing to disclose is a CAP code breach AND a Consumer Protection from Unfair Trading Regulations 2008 issue.
The two-part question
Affiliate marketing is regulated in two distinct ways. Both questions matter and the answers are independent.
Question 1 — Is the disclosure clear and prominent?
- At the top of a post, not buried in hashtags.
- In the opening seconds of a video, not at the end.
- Using clearly understood terms: #ad, #sponsored, ‘Paid partnership’, ‘affiliate link’.
- Platform-native disclosure tools enabled (Instagram Paid Partnership flag, YouTube paid-promotion banner, TikTok Branded Content toggle).
Question 2 — Is the underlying product or supply lawful?
Disclosure doesn’t cure substantive breaches. A well-disclosed affiliate post promoting:
- POM-direct-to-public supply → HMR 2012 Part 12 breach
- Unlicensed peptide with medicinal claims → engages MHRA
- ‘Compounded’ GLP-1 from unregulated sources → engages MHRA
- Counterfeit-supply funnel → criminal supply offences
...is still unlawful. The affiliate compensation makes you part of the supply chain, not just a commentator on it.
What affiliate models tend to attract enforcement
Influencer + DM-supplier funnels
Influencer posts a lifestyle / before-after image promoting a peptide protocol. Bio links to a Linktree or DM-funnel page. Final destination is an unregulated seller or DM conversation that completes the sale outside the regulated UK supply chain. Affiliate commission flows back to the influencer.
Multiple breach categories: undisclosed affiliate (CPR / CAP), POM advertising (HMR Part 12) or unlicensed medicinal claims (HMR regulation 2), and facilitation of unlawful supply (HMR Part 14).
Publisher / blog ‘best peptide supplier’ lists
Blog content ranking peptide retailers, with affiliate links paying commission per sale. Where the retailers sell unlicensed peptides as medicines or POMs without prescription, the publication is a facilitating advertiser. Disclosure doesn’t cure the underlying unlicensed-medicines issue.
Gym / PT affiliate codes
Gym or personal trainer posts a discount code earning commission on peptide-product sales. Combined with the out-of-scope problem already covered in gyms and personal trainers — supply / promotion of medicines or unlicensed substances is outside CIMSPA / REPS scope and outside professional indemnity insurance cover.
Clinic affiliate / referral schemes
A clinic paying influencers per referred consultation can be lawful where the clinic itself operates within UK rules (real GMC prescriber, real GPhC pharmacy, real assessment). Where the clinic is bypassing clinical-assessment standards or supplying unlawfully, the affiliate-paid traffic feeds the same enforcement target.
What lawful peptide-adjacent affiliate marketing looks like
- Affiliate revenue from licensed-cosmetic peptide topicals (GHK-Cu serums, Matrixyl-containing skincare) — cosmetic category, lower risk.
- Affiliate revenue from books, courses, supplements within food-supplement rules.
- Service-level affiliate revenue from licensed clinics where the consultation is a real clinical assessment and the prescribed medicine is a licensed UK product (with disclosure that the clinic, not the product, is the affiliate relationship).
- Publisher-disclosed sponsorship for editorial content (without product placement in the editorial itself).
What we do at Peptide Authority
The site has one disclosed commercial relationship: an affiliate link to Peptide Barn (research-peptide retailer) on selected peptide profile / blog / guide pages. The affiliate component is deliberately not rendered on safety / legal / faq / clinical-pathway pages. See we are not a peptide retailer and the conflict-of-interest policy for the full disclosure framework.
Reporting affiliate-disclosure failures
- ASA: make a complaint — covers undisclosed paid promotion.
- CMA: for systematic influencer or platform disclosure failures.
- MHRA: report a problem where affiliate marketing feeds unlawful medicines supply.
- Trading Standards via Citizens Advice consumer service.
Red-flag claims
If you see wording like this on a seller, clinic, or social-media advert, treat it as a warning sign rather than a benefit.
“My peptide stack — discount code MAX10 for 10% off (no #ad)”
Undisclosed affiliate. CAP + CPR breach. If the underlying product is unlicensed or POM, MHRA breach on top.
“The best GLP-1 supplier list — read our 2026 rankings”
Ranking peptide retailers via affiliate links makes the publisher part of the unlawful-supply chain if those retailers operate outside UK supply rules.
“Get £100 off Mounjaro via my link”
POM-direct-to-public promotion + affiliate. HMR 2012 Part 12 breach in addition to disclosure obligations.
“Sponsored content (badge at the bottom of the post)”
Disclosure must be clear and prominent — at the top of the post, in opening seconds of video. Bottom-of-post badges have been ruled non-compliant.
“Personal trainer recommends this peptide protocol — code DAN20”
PT outside scope of practice; affiliate undisclosed; substance likely unlicensed. Triple problem.
Sources & further reading
- ASA / CAP advertising codes — asa.org.uk
- ASA — influencer ad rules — asa.org.uk
- CMA — guidance on hidden advertising — gov.uk
- Consumer Protection from Unfair Trading Regulations 2008 — legislation.gov.uk
- Human Medicines Regulations 2012 — legislation.gov.uk
- Report a problem with a medicine or medical device — gov.uk
Frequently asked questions
- What's the basic UK rule on affiliate disclosure?
- If you receive any payment, commission, free product, or other benefit for promoting a product, you have a material connection that must be clearly and prominently disclosed in your content. ‘Clearly and prominently’ means at the top of the post or in the opening seconds of video, not buried in hashtags or descriptions.
- Can I do affiliate marketing for licensed UK GLP-1s?
- Direct promotion of POMs (Wegovy, Mounjaro, Ozempic, Saxenda, Rybelsus) to the general public is prohibited under HMR 2012 Part 12 — regardless of affiliate disclosure. You can affiliate-promote weight-management services that include consultations (where the prescriber decides whether a POM is appropriate); you can't affiliate-promote the POM itself to consumers.
- What about unlicensed peptides like BPC-157 or melanotan?
- Affiliate promotion combined with medicinal claims engages both the ASA (CAP code) and the MHRA (unlicensed-medicines supply). Affiliate-supporting medicinal claims for unlicensed substances is the pattern MHRA Criminal Enforcement Unit has acted against.
- What enforcement has actually happened?
- ASA has upheld many complaints against influencers and bloggers for undisclosed paid promotion across product categories. The CMA wrote to multiple major social-media personalities in past enforcement waves. MHRA has prosecuted online sellers and the websites that funnel traffic to them; the affiliate side of those funnels has been a target.
- If I run a publication / blog / podcast, can I take peptide affiliate revenue?
- Generally yes for licensed-product service categories with appropriate disclosure. Generally no for unlicensed-substance products. The line is whether the underlying supply is lawful — affiliate compensation for promoting unlawful supply doesn't become lawful because the disclosure is good.